1FX-3577274-7/10002/1

Novartis Pharmaceuticals Canada Inc. — FEI 3002260858

Refusal Details

Date
March 12, 2026
Country
Canada
Product Category
Drugs and Biologics
Product Code
60LCY14 CARBAMAZEPINE (ANALGESIC)
Charges
75